CalciMedica (CALC) Operating Leases (2022)

CalciMedica's (CALC) quarterly Operating Leases came in at $200000.0 in Q4 2022, up 96.08% on a QoQ basis from $102000.0 in Q1 2022.

CalciMedica (CALC) Operating Leases (2022) Analysis & Trends

CalciMedica (CALC) has 1 years of Operating Leases data on file, last reported at $200000.0 in Q4 2022.

Quarterly Operating Leases changed N/A year-over-year to $200000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $200000.0 (changed N/A YoY) and the FY2022 annual result came in at $200000.0, changed N/A from the prior year.
Operating Leases rose to $200000.0 in Q4 2022, from $102000.0 in the prior quarter.
In the past five years, Operating Leases ranged from a high of $200000.0 in Q4 2022 to a low of $102000.0 in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.83 Bn	130.98 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.79 Bn	77.79 Bn	3.93 Bn
3	Argenx Se	64.95 Bn	59.77 Bn	1.37 Bn
4	Moderna	58.59 Bn	53.46 Bn	52.00 Mn
5	BeOne Medicines	41.93 Bn	36.83 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.52 Bn	28.21 Bn	992.69 Mn
7	BioNTech SE	27.98 Bn	9.58 Bn	668.28 Mn
8	Insmed	27.42 Bn	26.26 Bn	358.27 Mn
9	Royalty Pharma	27.33 Bn	26.49 Bn	-
10	CalciMedica	9.71 Mn	-8.91 Mn	-

Download Data

Date	Value
Dec 31, 2022	200,000.00
Mar 31, 2022	102,000.00